Placenta previa occurs in approximately 0.4% pregnancies. It is defined by implantation of placenta in the lower uterine segment so that it partially or completely covers the internal os. It is usually diagnosed in the second half of pregnancy using vaginal sonography. Terminology is, however, still inconsistent. Classification, when taking into consideration sonography criterium, differentiates between placenta previa, where internal os is covered to any degree, and low-lying placenta, where the edge of placenta doesn’t cover internal os but is within 2 centimetres of it. Placenta previa could lead to further complications due to invasion of placental villi deep from basal plate causing placenta accrete syndrome. Position of placenta in the lower uterine segment, which has increased vascularity and low contractility, in most cases leads to characteristic vaginal bleeding, particularly in the third trimester of the pregnancy and the beginning of the labour. The women with the increased risk of recurring placenta previa are those who have previously undergone Caesarean section or other uterine surgeries, are of advanced age as well as multiparity and smoking. In women with stable placenta previa, an elective Caesarean section is usually accomplished at 36 or 37 weeks of pregnancy. However, due to repeated bleeding episodes, Caesarean often needs to be carried out earlier in the pregnancy. After delivery, severe bleeding from the implantation site is expected. Its suppression is a major challenge for clinicians. Maternal complications include massive bleeding (antepartum, intrapartum and postpartum), placenta accreta and hysterectomy. Neonatal complications associated with previa include preterm birth, congenital anomalies, respiratory distress syndrome and anemia. Multidisciplinary approach is the best way to reduce morbidity and mortality.